Literature DB >> 15834026

Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.

K Kimura1, K Minematsu, T Yamaguchi.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for stroke. AIMS: To assess whether AF in patients with acute ischaemic stroke is associated with severe stroke and early death. MATERIALS/
METHODS: Patients with acute ischaemic stroke (15,831) who were registered in the Japan Multicenter Stroke Investigators' Collaboration registry were analysed. The AF group comprised 3335 (21.1%) patients (median age, 75 years) and the non-AF group comprised 12,496 (78.9%) patients (median age, 70 years). The association between AF and severe stroke and early death was investigated by means of multivariate logistic regression analysis.
RESULTS: The admission National Institutes of Health Stroke Scale (NIHSS) score of the AF group was higher than that of the non-AF group (median, 12 v 5; p < 0.0001). Multivariate logistic regression analyses found that female sex, advanced age, AF, and a history of stroke were independent factors associated with severe stroke (NIHSS score, > or = 11). The mortality rate within 28 days after admission was 11.3% in the AF group and 3.4% in the non-AF group (p < 0.0001). Multivariate logistic regression analyses identified older age, AF, and NIHSS score at admission as independent factors associated with early death.
CONCLUSION: AF was a predictive factor for severe stroke and early death in acute ischaemic stroke. Careful cardiac evaluation and appropriate treatment are needed to improve outcome in patients with acute stroke and AF.

Entities:  

Mesh:

Year:  2005        PMID: 15834026      PMCID: PMC1739612          DOI: 10.1136/jnnp.2004.048827

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset.

Authors:  B Censori; M Camerlingo; L Casto; B Ferraro; G C Gazzaniga; B Cesana; A Mamoli
Journal:  Stroke       Date:  1993-04       Impact factor: 7.914

3.  Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group.

Authors:  L Candelise; G Pinardi; A Morabito
Journal:  Stroke       Date:  1991-02       Impact factor: 7.914

4.  Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.

Authors:  R Saxena; S Lewis; E Berge; P A Sandercock; P J Koudstaal
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

5.  Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

Authors:  H S Jørgensen; H Nakayama; J Reith; H O Raaschou; T S Olsen
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

6.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors:  P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

7.  The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.

Authors:  J Bogousslavsky; G Van Melle; F Regli
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

8.  Relation of atrial fibrillation and high haematocrit to mortality in acute stroke.

Authors:  G D Lowe; A J Jaap; C D Forbes
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

9.  Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.

Authors:  J I Sage; R L Van Uitert
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  57 in total

Review 1.  Antithrombotic treatment in atrial fibrillation.

Authors:  G Y H Lip; C J Boos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA.

Authors:  Fadar Oliver Otite; Priyank Khandelwal; Seemant Chaturvedi; Jose G Romano; Ralph L Sacco; Amer M Malik
Journal:  Neurology       Date:  2016-10-12       Impact factor: 9.910

Review 3.  Atrial Fibrillation Ablation and its Impact on Stroke.

Authors:  Kevin G Graves; Victoria Jacobs; Heidi T May; Michael J Cutler; John D Day; T Jared Bunch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-01-24

4.  Validation of a simple method for atrial fibrillation screening in patients with stroke.

Authors:  C Gandolfo; M Balestrino; C Bruno; C Finocchi; N Reale
Journal:  Neurol Sci       Date:  2015-04-30       Impact factor: 3.307

Review 5.  Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.

Authors:  Thomas F Deering
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 6.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

Review 7.  Prevention of Stroke in Patients With Atrial Fibrillation.

Authors:  Talal Moukabary; Gerald V Naccarelli
Journal:  J Atr Fibrillation       Date:  2011-12-20

8.  Atrial fibrillation in patients with ischemic stroke: A population-based study.

Authors:  Sandra Kruchov Thygesen; Lars Frost; Kim A Eagle; Søren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

9.  Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.

Authors:  Hans T H Tu; Bruce C V Campbell; Soren Christensen; Patricia M Desmond; Deidre A De Silva; Mark W Parsons; Leonid Churilov; Maarten G Lansberg; Michael Mlynash; Jean-Marc Olivot; Matus Straka; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis
Journal:  Int J Stroke       Date:  2013-03-12       Impact factor: 5.266

10.  Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).

Authors:  Naoki Saji; Kazumi Kimura; Yohei Tateishi; Shigeru Fujimoto; Nobuyuki Kaneko; Takao Urabe; Akira Tsujino; Yasuyuki Iguchi
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.